Dr. Steven Almany, MD

Dr. Steven Almany, MD

Cardiology  ·  
Male  ·  
Age 61
(28)
Save
Dr. Steven Almany, MD is a cardiology specialist in Troy, MI and has been practicing for 27 years. He graduated from Michigan State University College Of Human Medicine in 1984 and specializes in cardiology and interventional cardiology.

4600 Investment Dr Ste 200

Troy, MI 48098

Contact Information

Insurance Accepted

  • Aetna
  • Blue Cross Blue Shield
  • Cigna
  • First Health (Coventry Health Care)
  • HAP Insurance
  • Humana
  • MultiPlan
  • Priority Health

*Please verify this information when scheduling an appointment.

Learn about Dr. Almany

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you.

Top Care Areas

See how frequently Dr. Almany performs your care needs compared to other doctors.

Coronary Artery Disease (CAD)
very high
more than 98% of peers
Hyperlipidemia
very high
more than 97% of peers
Hypertension
very high
more than 97% of peers

Dr. Almany's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

Care Philosophy

This content was provided by Dr. Almany "Michigan Heart Group was established in 1991 by David Cragg, M.D., and was soon joined by Steven Almany, M.D. The practice grew steadily, and Steven Ajluni, M.D, William Devlin, M.D, and later Terry Bowers, M.D. joined the practice. In the last several years we have added three more physicians, Brian Williamson, M.D, Ilana Kutinsky, D.O. and Michael Gallagher, M.D.. Both Drs. Kutinsky and Williamson specialize in electrophysiology, while Dr. Gallagher specializes in CT-angiograms. This new addition help Michigan Heart Group become one of the most comprehensive practices in Southeast Michigan encompassing every aspect of cardiovascular health care, this side of surgery. We specialize in clinical, diagnostic, interventional cardiology, vascular medicine and electrophysiology"
Less
Read Less

2  Specialties

  • Cardiology
  • Interventional Cardiology

3  Board Certifications

  • Cardiovascular Disease
    Accredited by: American Board of Internal Medicine*
  • Internal Medicine
    Accredited by: American Board of Internal Medicine*
  • Interventional Cardiology
    Accredited by: American Board of Internal Medicine*

48  Conditions Treated

  • Aneurysm
  • Angina and Acute Coronary Syndrome
  • Aortic Aneurysm
  • Aortic Ectasia
  • Aortic Stenosis
  • Aortic Valve Disease
  • Aortic Valve Regurgitation
  • Arrhythmias
  • Atrial Fibrillation
  • Atrial Flutter
  • Benign Tumor
  • Cardiomegaly
  • Cardiomyopathy
  • Carotid Artery Disease
  • Chest Pain
  • Chronic Pulmonary Heart Diseases (incl. Pulmonary Hypertension)
  • Congenital Aortic Valve Disorders
  • Congenital Heart Defects
  • Congenital Heart Disease
  • Congestive Heart Failure
  • Coronary Artery Aneurysm
  • Coronary Artery Disease (CAD)
  • Endocarditis
  • Heart Attack (Acute Myocardial Infarction)
  • Heart Disease
  • Heart Murmur
  • Heart Palpitations
  • Hyperlipidemia
  • Hypertension
  • Hypertensive Chronic Kidney Disease
  • Hypertensive Heart and Chronic Kidney Disease
  • Hypotension
  • Limb Swelling
  • Limb Swelling Caused by Fluid Overload
  • Mitral Valve Disease
  • Mitral Valve Regurgitation
  • Mitral Valve Stenosis
  • Pericardial Disease
  • Pulmonary Disease
  • Pulmonary Edema
  • Pulmonary Hypertension
  • Pulmonary Valve Disease
  • Secondary Hypertension
  • Septal Defect
  • Syncope
  • Thrombosis
  • Tricuspid Valve Disease
  • Vascular Disease
Less
Read Less

17  Procedures

Background Check

Malpractice Claims not available

Healthgrades does not collect malpractice information for Michigan.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • Michigan State University
    Undergraduate School | Graduated 1980
  • Michigan State University College Of Human Medicine
    Medical School | Graduated 1984
  • Wm Beaumont
    Internship Hospital | Completed 1985
  • Wm Beaumont
    Residency Hospital | Completed 1987
  • Wm Beaumont
    Fellowship Hospital | Completed 1991

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
  • US Patents 60/099,956 (Wrist Splint), 1998
  • US Patent PCT/US99/20754 (Hemostasis Device), 1999
  • Norman Horowitz Research Award, 1990
  • American College of Physicians National Clinical Poster Finalist, 1990
  • Best Doctors (National), 2004-Prese
  • Phi Beta Kappa- Michigan State University, 1980
  • Resident of the Year- William Beaumont Hospital, Royal Oak, 1986
  • Alpha Omega Alpha- Michigan State University, 1984
  • HOUR Magazine Top Doc (Michigan) Cardiology, 2000-Prese
Media & Publications
  • Cardiovascular Evaluation of the Athlete, 1994
  • Assisted PTCA, 1995
  • Acute Interventions In Myocardial Infarction,
  • A Guide for Practicing Physicians, 1999
  • Radial /Brachial Artery Access for Intervention,
  • Interventional Strategies in Patients with Left Ventricular Dysfunction, 1996
  • Interventional Strategies in Patients with Left Ventricular Dysfunction, 1992
  • Radial and Brachial Artery Based Access for Diagnostic and Interventional Procedures, 2002
  • Brachial and Radial Intervention, 2001
  • Preoperative Cardiac Evaluation, 1995
  • Pearls in Medicine: Caution with Anti-Ulcer Medication, 1995
  • Feasibility of Stenting in Acute Myocardial Infarction, 1995
  • Stenting in Acute Myocardial Infarction (STAMI): Six Month Follow-Up, 1997
  • Stenting of an Ostial Left Internal Thoracic Artery Stenosis. IT FITS! (Intelligence Transfer: From Images to Solutions) column, 1999
  • Long Term Treatment with a Platelet Glycoprotein Receptor Antagonist After Percutaneous Coronary Revascularization, 2000
  • High Frequency Vibration for the Recanalization of Guidewire Refractory Chronic Total Coronary Occlusions, 2008
  • Fibrin Sealant Closure of Refractory Pulmonary Air-Leak in an Emphysematous Patient with Spontaneous Pneumothorax, 1987
  • Primary Angioplasty in Patients Typically Excluded from Intravenous Thrombolysis, 1990
  • Angioplasty Compliance Trial (ACT): Prospective Randomized Trial of Coronary Angioplasty with Compliant and Noncompliant Balloons, 1994
  • Facilitated Lumen Enlargement by Longitudinal Force Focused Angioplasty, 1995
  • Improved Accuracy of Lesion Length Assessment During Percutaneous Coronary Intervention Using a New Vessel Caliper, 2001
  • Efficacy of a Distal Protection Filter During Saphenous Vein Graft Stent Implantation. Impact of Technical Factors and Learning Curve, 2002
  • Coronary Artery Stent Thrombosis Associated with Heparin-Induced Thrombocytopenia: Case Report and Review of the Literature, 2005
  • In Hospital CSTs are Increased with Adjunctive Thrombolytic Therapy in the Setting of Primary Angioplasty Therapy of Acute Myocardial Infarction, 1992
  • A Randomized Trial Comparing the Quickseal Femoral Arterial Closure Device with Manual Control After Diagnostic and Interventional Catheterization Procedures, 2002
  • Stroke Prevention in Non-Valvular Atrial Fibrillation : Long TermResults of the WATCHMAN Left Atrial Appendage Occlusion Pilot Study, 2009
  • Cost-Benefit Analysis of Transfemoral Aortic Valve Implantation (TAVI) for Treatment of Aortic Stenosis,
  • A Randomized Trial Comparing the Quickseal Arterial Closure Device to Manual Compression Following Interventional and Diagnostic Catheterization Procedures, 2002
  • Long Lesion Assessment Using a New Vessel Caliper. Catheterization and Cardiovascular Interventions, 2003
  • Long Term Patency and Incidence of Restenosis after Primary Angioplasty Therapy of Acute Myocardial Infarction, 1991
  • Hemodynamic Parameters 12-hours After Onset of Cardiogenic Shock Can Predict Survival, 1992
  • Restenosis After Coronary Intervention is Associated with Excessive Deposition of Cross-Linked "Scar" Collagen., 1995
  • Atrial Fibrillation Does Not Degrade the Clinical Benefits From Enhanced External Counterpulsation Therapy in Patients with Chronic Angina: Results From the International EECP Patient Registry, 2003
  • Early Hospital Discharge After Percutaneous Transluminal Angioplasty, 1989
  • No Reflow No More?, 1996
  • A Comparison of Balloon Pumping (IABP) with Cardiopulmonary Support (CPS) for High Risk PTCA, 1994
  • Stenting in Acute Myocardial Infarction (STAMI): Bailout, Conditional and Planned Stents, 1997
  • Local Drug Delivery of Intramural Ethyl Alcohol for Treatment of Diffuse In-Stent Restenosis: The Beaumont Alcohol Restenosis Study (BARS), 2001
  • Value of Transesophageal Echocardiography During Complex or High Risk Coronary Interventions in the Cardiac Catheterization Laboratory, 1991
  • Aggressive Treatment of Acute Myocardial Infarction, 1993
  • Initial Worldwide Experience with the WATCHMAN Left Atrial Appaendage System for Stroke Prevention In Atrial Fibrillation, 2007
  • A Prospective Pilot Study of Primary Stenting for Acute Myocardial Infarction (STAMI): Preliminary Results, 1996
  • Deterioration of Microvascular Flow after Stenting in Acute Anterior Myocardial Infarction, 2000
  • Intracoronary Radiation Therapy for the Treatment of Instent Restenosis: The Beaumont Experience, 2002
  • Comparison of Coronary Angioplasty with Compliant and Non-compliant Balloons (The Angioplasty Compliance Trial), 1995
  • Evaluation of a Weight-Adjusted Single-bolus Plasminogen Activator in Pataients with Myocardial Infarction. A Double-blind, Randomized Angiographic Trial of Lanoteplase Versus Alteplase, 1998
  • Left Atrial Appendage Septae Not Visualized with TEE. Catheterization and Cardiovascular Interventions, 2006
  • Tetracycline Chemical Pleurodesis for Spontaneous Pneumothorax, 1987
  • Interim Safety Analysis of the Beaumont Outpatient Angioplasty Trial, 1991
  • Use of a Compressive Leverage Apparatus Versus Manual Pressure in Achieving Hemostasis after Invasive Procedures, 1993
  • Facilitated Lumen Enlargement by Longitudinal Force Focused Angioplasty, 1995
  • Matrix VSG Randomized Trial. A new Synthetic Exxtravascular Bioresorbable, Hydrogel Sealant Resulting in Significant Reduction in Times to Hemostasis and Ambulation and Complications Equivalent to Standard Copression, 2005
  • Student Heart Check Interview 97.1, 12/09/12
  • Student Heart Check Interview with Drew Staton, 12/09/12

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Almany does not have any memberships or affiliations listed. If you are Dr. Almany and would like to add memberships or affiliations, please update your profile.

Dr. Almany's Reviews

4.8
Likelihood of recommending Dr. Almany to family and friends
28 total reviews (2 have comments)

Likelihood to Recommend (28)

  • 5
    (26)
  • 4
    (0)
  • 3
    (1)
  • 2
    (0)
  • 1
    (1)

Dr. Almany's Performance

  • Trustworthiness

    EXCELLENT
  • Explains condition(s) well

    EXCELLENT
  • Answers questions

    EXCELLENT
  • Time well spent

    EXCELLENT

Office & Staff Performance

  • Scheduling

    EXCELLENT
  • Office environment

    EXCELLENT
  • Staff friendliness

    EXCELLENT
  • Average wait time

    10 to 15 minutes

Patient Comments (2)

From the moment he walked into the room he was brilliant and had a wonderful personality and I felt like he was actually listening to my concerns.. I have not had a doctor that I have liked in 20 years. Highly recommend.
Was this helpful? thumbs up icon option0thumbs down icon option0
Flag this
excellant
Was this helpful? thumbs up icon option6thumbs down icon option3
Flag this
Image of Dr. Almany
Are you Dr. Almany?
Make it easy for patients to share their feedback. Also manage your personalized profile!